Compass Capital Corp MA ADV Makes New Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Compass Capital Corp MA ADV acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 970 shares of the medical equipment provider's stock, valued at approximately $506,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the fourth quarter worth about $26,000. MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical in the 3rd quarter worth approximately $33,000. Decker Retirement Planning Inc. bought a new position in Intuitive Surgical during the 4th quarter valued at approximately $36,000. Sierra Ocean LLC bought a new stake in Intuitive Surgical in the fourth quarter worth $40,000. Finally, Capital Performance Advisors LLP purchased a new stake in shares of Intuitive Surgical in the third quarter worth $38,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of the business's stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares of the company's stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 269 shares of the firm's stock in a transaction on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares of the company's stock, valued at $1,936,380. The trade was a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 6,348 shares of company stock valued at $3,587,582 over the last ninety days. 0.90% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on ISRG. UBS Group boosted their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a report on Monday, January 27th. Raymond James lifted their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a research note on Thursday, December 5th. Piper Sandler reaffirmed an "overweight" rating and set a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Finally, Leerink Partners boosted their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $613.10.

Intuitive Surgical Price Performance

Shares of ISRG stock traded up $0.82 on Monday, hitting $592.61. 726,575 shares of the stock traded hands, compared to its average volume of 1,695,098. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The firm has a 50 day simple moving average of $565.45 and a two-hundred day simple moving average of $525.60. The firm has a market cap of $211.07 billion, a price-to-earnings ratio of 92.62, a PEG ratio of 5.85 and a beta of 1.39.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.